Lipid nanoparticles loaded with ribonucleoprotein–oligonucleotide complexes synthesized using a microfluidic device exhibit robust genome editing and hepatitis B virus inhibitionYuichi Suzuki, Hideyoshi Harashima, Haruno Onuma et al.|Journal of Controlled Release|2020Cited by 97